inTEST (INTT 1.57%), a supplier of test and process technology solutions for high-growth industrial markets, released its second quarter 2025 results on August 6, 2025. The earnings report revealed a modest outperformance: adjusted earnings per share (Non-GAAP) was $0.03 for Q2 2025, topping the $(0.03) consensus. Revenue (GAAP) reached $28.1 million in Q2 2025, just above the $28.0 million estimate, though the company still saw a 17.2% decline from the same quarter last year. Overall, the results for Q2 20 ...

inTEST (INTT) Q2 2025 Earnings Call August 06, 2025 08:30 AM ET Speaker0Greetings and welcome to the InTest Corporation Second Quarter twenty twenty five Financial Results Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Sean Southard, Investor Relations for InTest.Thank you. You may begin.Speaker1Good morning, everyone. We ce ...

Nick Grant, President and CEO Duncan Gilmour, CFO and Treasurer NYSE American: INTT | NYSE American: INTT | Second Quarter 2025 Financial Results Conference Call August 6, 2025 statements. Such risks and uncertainties include, but are not limited to, any mentioned in this presentation as well as the Company's ability to execute on its Vision 2030 Growth Strategy, realize the potential benefits of acquisitions and successfully integrate any acquired operations, grow the Company's presence in its key target a ...

Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Orders Improved 10% and Gross Margin Expanded 110 basis points Sequentially to 42.6% for Second Quarter 2025 MT. LAUREL, NJ – August 6, 2025 -- InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor ("semi"), automotive/EV, defense/aerospace, industr ...

Group 1 - inTEST (NYSE: INTT) is currently priced under $7 per share, presenting an interesting investment opportunity [1] - The company is experiencing fundamental pressure on sales and margins due to weaker end-market conditions [1] - The potential bullish case for inTEST suggests that the current challenges may not reflect the long-term viability of the business [1]

PART I. FINANCIAL INFORMATION [Item 1. Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) The company reported a Q1 2025 net loss of $2.3 million, a significant downturn from a $0.7 million net earning in Q1 2024 [Consolidated Balance Sheets](index=3&type=section&id=Consolidated%20Balance%20Sheets) Total assets decreased to $148.0 million as of March 31, 2025, mainly due to a reduction in trade accounts receivable Consolidated Balance Sheet Highlights (in thousands) | Account | March 31, 2025 (Unaudited) | December 31, 2024 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $22,048 | $19,830 | | Trade accounts receivable, net | $21,178 | $29,495 | | Inventories | $27,608 | $26,837 | | Goodwill | $31,236 | $30,744 | | **Total Assets** | **$148,027** | **$152,288** | | **Liabilities & Equity** | | | | Current portion of long-term debt | $6,876 | $7,494 | | Long-term debt, net | $4,952 | $7,538 | | **Total Liabilities** | **$48,632** | **$52,498** | | **Total Stockholders' Equity** | **$99,395** | **$99,790** | [Consolidated Statements of Operations](index=4&type=section&id=Consolidated%20Statements%20of%20Operations) Q1 2025 revenue decreased 10.7% year-over-year, resulting in a net loss of $2.3 million versus a prior-year net earning Q1 2025 vs. Q1 2024 Statement of Operations (in thousands, except per share data) | Metric | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Revenue | $26,637 | $29,824 | | Gross Profit | $11,056 | $13,076 | | Operating (Loss) Income | $(2,881) | $492 | | Net (Loss) Earnings | $(2,329) | $662 | | Diluted (Loss) Earnings Per Share | $(0.19) | $0.05 | [Consolidated Statements of Cash Flows](index=7&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) Net cash from operations improved to $5.5 million in Q1 2025, driven by a significant decrease in accounts receivable Q1 2025 vs. Q1 2024 Cash Flow Summary (in thousands) | Cash Flow Activity | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Net cash provided by operating activities | $5,535 | $2,075 | | Net cash used in investing activities | $(229) | $(19,244) | | Net cash used in financing activities | $(3,406) | $(874) | | **Net cash provided by (used in) all activities** | **$2,218** | **$(17,929)** | | **Cash and cash equivalents at end of period** | **$22,048** | **$27,331** | [Notes to Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) Notes detail segment performance, the Alfamation acquisition, a restructuring plan, and a significant debt covenant breach - The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies, with a strategic focus on diversifying away from the volatile semiconductor market into areas like auto/EV, defense/aerospace, and life sciences[21](index=21&type=chunk)[24](index=24&type=chunk)[25](index=25&type=chunk) - On March 12, 2024, the company acquired Alfamation S.p.A. for an aggregate purchase price of approximately **€20.0 million ($21.9 million)**, consisting of cash and stock[91](index=91&type=chunk)[94](index=94&type=chunk) - The company is in breach of its fixed charge coverage ratio covenant (**0.99 to 1.0 vs. required 1.25 to 1.0**) as of March 31, 2025, and anticipates non-compliance for Q2 2025[127](index=127&type=chunk)[189](index=189&type=chunk)[236](index=236&type=chunk) - In February 2025, a restructuring plan was initiated to consolidate Videology Imaging Corporation's Netherlands operations, resulting in **$313 thousand of restructuring charges** in Q1 2025[162](index=162&type=chunk)[163](index=163&type=chunk) Revenue by Segment (in thousands) | Segment | Q1 2025 Revenue | Q1 2024 Revenue | | :--- | :--- | :--- | | Electronic Test | $13,259 | $11,116 | | Environmental Technologies | $6,268 | $6,828 | | Process Technologies | $7,110 | $11,880 | | **Total** | **$26,637** | **$29,824** | [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=50&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management attributes the revenue decline to the semi market, discusses margin contraction, and highlights a debt covenant breach [Results of Operations](index=56&type=section&id=Results%20of%20Operations) Q1 2025 revenue fell 10.7% due to a semi market decline, while the Alfamation acquisition drove Electronic Test segment growth Revenue by Market (in thousands) | Market | Q1 2025 | Q1 2024 | Change $ | Change % | | :--- | :--- | :--- | :--- | :--- | | Semi | $8,995 | $14,967 | $(5,972) | (39.9)% | | Auto/EV | $5,959 | $3,958 | $2,001 | 50.6% | | Defense/aerospace | $2,828 | $3,239 | $(411) | (12.7)% | | Industrial | $3,021 | $4,187 | $(1,166) | (27.8)% | | Life Sciences | $1,688 | $653 | $1,035 | 158.5% | | **Total Revenue** | **$26,637** | **$29,824** | **$(3,187)** | **(10.7)%** | - Q1 2025 orders increased **11.2% year-over-year to $25.3 million**, driven by strength in industrial, auto/EV, and life science markets[199](index=199&type=chunk)[200](index=200&type=chunk) - Backlog of unfilled orders was **$38.2 million** at March 31, 2025, down from $55.5 million at March 31, 2024[202](index=202&type=chunk) - Gross margin decreased by **230 basis points to 41.5%** due to lower absorption of fixed costs on lower sales volumes and an unfavorable product mix[203](index=203&type=chunk) - Operating expenses increased, with Engineering and Product Development up **23.5%** and G&A up **7.4%**, primarily due to the Alfamation acquisition[206](index=206&type=chunk)[207](index=207&type=chunk) [Liquidity and Capital Resources](index=60&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains solid liquidity but breached a key debt covenant, for which it obtained a waiver but expects future non-compliance Liquidity Snapshot (in thousands) | Metric | March 31, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Cash and cash equivalents | $22,048 | $19,830 | | Working capital | $43,594 | $46,864 | - The company was **not in compliance with its fixed charge coverage ratio covenant (0.99 to 1.0)** for Q1 2025 and received a one-time waiver[215](index=215&type=chunk) - As of March 31, 2025, **$12.0 million (55%) of cash and cash equivalents** was held by foreign subsidiaries[220](index=220&type=chunk) - Cash from operating activities increased to **$5.5 million** in Q1 2025 from $2.1 million in Q1 2024, driven by improved collections of accounts receivable[224](index=224&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=63&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This disclosure is not required as the company qualifies as a smaller reporting company - As a smaller reporting company, InTest Corporation is not required to provide this disclosure[229](index=229&type=chunk) [Item 4. Controls and Procedures](index=63&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of the quarter-end with no material changes - The CEO and CFO concluded that as of the end of the reporting period, the company's disclosure controls and procedures were **effective at the reasonable assurance level**[231](index=231&type=chunk) - No changes occurred during the quarter that materially affected, or are reasonably likely to materially affect, the company's internal control over financial reporting[232](index=232&type=chunk) PART II. OTHER INFORMATION [Item 1. Legal Proceedings](index=64&type=section&id=Item%201.%20Legal%20Proceedings) The company is not currently involved in any material legal proceedings - The company is **not currently a party to any material legal proceedings**[234](index=234&type=chunk) [Item 1A. Risk Factors](index=64&type=section&id=Item%201A.%20Risk%20Factors) Key risks include the impact of restrictive debt covenants and potential disruptions from U.S. and foreign trade policies - A key risk is the potential adverse impact of credit facility covenants, as the company was **not in compliance with its fixed charge coverage ratio** at March 31, 2025[235](index=235&type=chunk)[236](index=236&type=chunk) - U.S. tariff policies and global retaliatory measures pose a significant risk, as approximately **52% of Q1 2025 revenue was from shipments outside the United States**[237](index=237&type=chunk)[238](index=238&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=65&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company renewed its $10.0 million share repurchase plan but made no repurchases during the quarter - On March 5, 2025, the Board renewed the share repurchase plan, authorizing up to **$10.0 million in repurchases**, with about $9.0 million available[240](index=240&type=chunk) - **No shares were repurchased** under the plan in Q1 2025, though 646 shares were acquired from employees to satisfy tax liabilities on vested stock awards[240](index=240&type=chunk)[241](index=241&type=chunk) [Item 3. Defaults Upon Senior Securities](index=65&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) The company reported no defaults upon senior securities during the period - None[242](index=242&type=chunk) [Item 4. Mine Safety Disclosures](index=65&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This section is not applicable to the company's operations - Not applicable[243](index=243&type=chunk) [Item 5. Other Information](index=66&type=section&id=Item%205.%20Other%20Information) No directors or officers adopted or terminated Rule 10b5-1 trading arrangements during the first quarter - No directors or officers adopted or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement in Q1 2025[244](index=244&type=chunk) [Item 6. Exhibits](index=66&type=section&id=Item%206.%20Exhibits) This section lists all exhibits filed with the Form 10-Q, including certifications and XBRL data files Signatures [Signatures](index=67&type=section&id=Signatures) The report was duly signed by the company's Principal Executive Officer and Principal Financial Officer - The report is signed by the Principal Executive Officer and Principal Financial Officer[249](index=249&type=chunk)

inTEST (INTT) Q1 2025 Earnings Call May 02, 2025 08:30 AM ET Company Participants Shawn Southard - Investor RelationsRichard Grant - President & CEODuncan Gilmour - CFO, Treasurer & SecretaryJaeson Schmidt - Director of Research Conference Call Participants Richard Ryan - Vice President, Senior Research AnalystTed Jackson - MD & Senior Research Analyst Operator Greetings and welcome to the Intest Corporation First Quarter twenty twenty five Financial Results. At this time, all participants are in a listen o ...

inTEST (INTT) Q1 2025 Earnings Call May 02, 2025 08:30 AM ET Speaker0 Greetings and welcome to the Intest Corporation First Quarter twenty twenty five Financial Results. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Sean Suthardt, Investor Relations with nTest. Thank you. You may begin. Speaker1 Good morning, everyone. We certain ...

分组1 - InTest Corporation reported a quarterly loss of $0.11 per share, missing the Zacks Consensus Estimate of a loss of $0.08, and compared to earnings of $0.10 per share a year ago, representing an earnings surprise of -37.50% [1] - The company posted revenues of $26.64 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 6.11%, and down from $29.82 million year-over-year [2] - InTest shares have declined approximately 27.6% since the beginning of the year, contrasting with the S&P 500's decline of -4.7% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.09 on revenues of $31.91 million, and for the current fiscal year, it is $0.39 on revenues of $130.15 million [7] - The Zacks Industry Rank for Electronics - Measuring Instruments is currently in the bottom 18% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

First Quarter 2025 Financial Results Conference Call Nick Grant, President and CEO Duncan Gilmour, CFO and Treasurer May 2, 2025 | NYSE American: INTT | 1 Forward-looking Statements and Key Performance Metrics NYSE American: INTT | 2 Non-GAAP Financial Measures In addition to disclosing results that are determined in accordance with generally accepted accounting practices in the United States ("GAAP"), we also disclose non- GAAP financial measures. These non-GAAP financial measures consist of adjusted net e ...